Table 10 Age distribution of the patients from which the various samples were obtained
From: Pan-cancer analysis of TCGA data reveals notable signaling pathways
Cancer | Tumor samples | Non-tumor samples | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | 0-20 | 21-40 | 41-60 | 61-80 | 81-100 | NA | 0-20 | 21-40 | 41-60 | 61-80 | 81-100 | NA |
Breast cancer | 0 | 51 | 198 | 194 | 22 | 1 | 0 | 7 | 26 | 25 | 3 | 0 |
Colon adenocarcinoma | 0 | 2 | 22 | 90 | 29 | 0 | 0 | 0 | 3 | 12 | 4 | 0 |
Glioblastoma | 7 | 63 | 238 | 237 | 20 | 2 | 0 | 1 | 4 | 4 | 1 | 0 |
Kidney renal papillary cell carcinoma | 0 | 0 | 11 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Low grade glioma | 1 | 15 | 10 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Lung adenocarcinoma | 0 | 1 | 9 | 20 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Lung squamous cell carcinoma | 0 | 2 | 31 | 112 | 7 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Ovarian carcinoma | 0 | 23 | 295 | 233 | 20 | 1 | 0 | 4 | 4 | 0 | 0 | 0 |
Rectum adenocarcinoma | 0 | 1 | 14 | 47 | 7 | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
Uterine corpus endometriod carcinoma | 0 | 3 | 23 | 22 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pan-cancer (total) | 8 | 161 | 851 | 961 | 113 | 6 | 0 | 12 | 38 | 43 | 8 | 0 |